We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-5.17%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$6.16B
AUM Growth
-$821M
Cap. Flow
-$392M
Cap. Flow %
-6.36%
Top 10 Hldgs %
16.27%
Holding
911
New
217
Increased
113
Reduced
100
Closed
202

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$145M
2
ASML icon
ASML
ASML
+$119M
3
QRVO icon
Qorvo
QRVO
+$89M
4
MSFT icon
Microsoft
MSFT
+$82.9M
5
ISRG icon
Intuitive Surgical
ISRG
+$75.5M

Sector Composition

Rank Sector Weight
1 Healthcare 38.56%
2 Technology 29.01%
3 Industrials 8.79%
4 Communication Services 5.99%
5 Financials 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACDI.WS
526
DELISTED
Ascendant Digital Acquisition Corp. III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11. 50 per share
ACDI.WS
$383K 0.01%
+956,250
New +$455K
CLDI.WS
527
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$356K 0.01%
990,000
DMYS.WS
528
DELISTED
dMY Technology Group, Inc. VI Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
DMYS.WS
$345K 0.01%
500,000
COCO icon
529
Vita Coco
COCO
$3.71B
$336K 0.01%
37,500
ZEV.WS
530
DELISTED
Lightning eMotors, Inc. Redeemable Warrants, each whole warrant exercisable 1/20th of a share of common stock at an exercise price of $230.00 per whole share
ZEV.WS
$336K 0.01%
+343,101
New +$337K
STRO icon
531
Sutro Biopharma
STRO
$400M
$319K 0.01%
+3,878
New +$369K
ENFN
532
DELISTED
Enfusion, Inc.
ENFN
$318K 0.01%
25,000
ROIVW
533
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
$316K 0.01%
359,337
APCA
534
DELISTED
AP Acquisition Corp
APCA
$300K ﹤0.01%
+30,000
New +$298K
SPRY icon
535
ARS Pharmaceuticals
SPRY
$551M
$293K ﹤0.01%
83,571
-410,324
-83% -$1.79M
COGT icon
536
Cogent Biosciences
COGT
$7.14B
$276K ﹤0.01%
+36,783
New +$256K
ARIS
537
DELISTED
Aris Water Solutions
ARIS
$273K ﹤0.01%
15,000
SERA icon
538
Sera Prognostics
SERA
$78.3M
$262K ﹤0.01%
69,095
-59,049
-46% -$343K
CERO
539
DELISTED
CERo Therapeutics
CERO
$250K ﹤0.01%
13
TVGN icon
540
Tevogen Inc. Common Stock
TVGN
$27.3M
$250K ﹤0.01%
+500
New +$249K
IQMD
541
DELISTED
Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
$250K ﹤0.01%
+25,000
New +$248K
APN
542
DELISTED
Apeiron Capital Investment Corp
APN
$250K ﹤0.01%
+25,000
New +$249K
RCFA
543
DELISTED
Perception Capital Corp. IV
RCFA
$249K ﹤0.01%
+25,000
New +$247K
SZZL
544
DELISTED
Sizzle Acquisition Corp. Common stock
SZZL
$249K ﹤0.01%
+25,000
New +$249K
BCSA
545
DELISTED
Blockchain Coinvestors Acquisition Corp. I Class A Ordinary Shares
BCSA
$248K ﹤0.01%
+25,000
New +$247K
SGII
546
DELISTED
Seaport Global Acquisition II Corp. Class A Common Stock
SGII
$248K ﹤0.01%
+25,000
New +$247K
CXAC
547
DELISTED
C5 Acquisition Corporation
CXAC
$248K ﹤0.01%
+25,000
New +$248K
URBN icon
548
Urban Outfitters
URBN
$6.65B
$246K ﹤0.01%
+9,780
New +$267K
DLCA
549
DELISTED
Deep Lake Capital Acquisition Corp. Class A Ordinary Shares
DLCA
$217K ﹤0.01%
22,131
STRE.U
550
DELISTED
Supernova Partners Acquisition Company III, Ltd. Units, each consisting of one Class A ordinary share and one-fifth of one redeemable warrant
STRE.U
$208K ﹤0.01%
21,357

Similar funds

Woodline Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Woodline Partners held 911 positions worth $6.16B, down 12% from $6.98B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners withdrew a net $392M in Q1 2022, closing 202 positions and reducing 100 holdings. Its most notable exit was AbbVie, an estimated $145M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.

Against the trend, Woodline Partners opened a new position in ZYNGA INC. CL A COMMON worth $102M.

  • Woodline Partners's largest Q1 2022 buy was ZYNGA INC. CL A COMMON: 11,039,458 shares worth $102M.
  • Woodline Partners added most to Seagen Inc. Common Stock in Q1 2022, an estimated $100M increase.
  • Woodline Partners's biggest Q1 2022 reduction was Qorvo, cutting an estimated $89M.
  • Woodline Partners fully exited AbbVie in Q1 2022, selling an estimated $145M.
  • Woodline Partners's ten largest holdings make up 16% of its $6.16B portfolio in Q1 2022.
  • Woodline Partners opened 217 new positions and closed 202 in Q1 2022.
  • Woodline Partners's portfolio value fell 12% quarter-over-quarter to $6.16B.

Based on Woodline Partners's 13F filing for Q1 2022, filed 16 May 2022.